• India
More

    Bharat Biotech expands its manufacturing capacity to produce 70 crore doses of Covaxin annually

    Must Read

    Vadodara collector a shining example of motherhood

    Spend quality time with her children after back home from work The role of...

    Covid 19 cases reached 52446 in Vadodara after 967 new cases on Sunday

    Total 534 discharged from hospital taking the total to 42010 The number of positive...

    Chinese rocket debris falls into Indian Ocean

    The remains of a Chinese rocket crashed into the Indian Ocean on Sunday with much of the...

    Bharat Biotech has expanded its manufacturing capacity across multiple facilities in Hyderabad and Bangalore to produce 700 million doses of Covaxin annually.

    The government on Monday approved a payment of about 4,500 crore rupees as advance to vaccine makers including Bharat Biotech and Serum Institute of India (SII) that is producing AstraZeneca’s Covishield in India.

    The move came ahead of opening the vaccination drive to all citizens over 18 years of age. SII will supply 200 million doses and Bharat Biotech is set to supply another 90 million doses to the government by July at a pre-agreed rate of 150 rupees per dose.

    Bharat Biotech said manufacturing has been scaled up in a step-wise manner, and raw and packing materials, and single-use consumables have been secured adequately. The company said it is able to expand Covaxin’s manufacturing capacity in a short time due to the availability of new specially designed BSL-3 facilities, a first-of-its-kind for manufacturing in India.

    Bharat Biotech said, manufacturing partnerships are being explored in other countries with facilities that have prior expertise with commercial scale manufacture of inactivated viral vaccines under biosafety containment.

    To further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the capabilities and expertise to manufacture inactivated viral vaccines at commercial scale and under biosafety containment.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Latest News

    Himanta Biswa Sarma chosen Assam’s new chief minister

    Himanta Biswa Sarma was named the next chief minister of Assam on Sunday and he will replace...

    Covid 19 cases reached 52446 in Vadodara after 967 new cases on Sunday

    Total 534 discharged from hospital taking the total to 42010 The number of positive cases in Vadodara reached 52446...

    Chinese rocket debris falls into Indian Ocean

    The remains of a Chinese rocket crashed into the Indian Ocean on Sunday with much of the debris burning up during the...

    Pickup van crushed one and half year old playing near home in Vadodara

    Driver fled from the spot locals vandalised the van demand justice A Bolero Pickup van crushed a one and...

    Himanta Biswa Sarma chosen Assam’s new chief minister

    Himanta Biswa Sarma was named the next chief minister of Assam on Sunday and he will replace incumbent Sarbananda Sonowal to the...

    More Articles Like This

    - Advertisement -